Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anjali Naik"'
Autor:
Kateryna Fedorov, Tanim Jain, Kith Pradhan, Jennat Mustafa, Amanda Lombardo, Fariha Khatun, Felisha Joseph, Kailyn Gillick, Anjali Naik, Richard Elkind, Karen Fehn, Alyssa de Castro, Roy Browne, Michelly Abreu, Donika Binakaj, Monika Paroder, Carlo Palesi, Kira Gritsman, R Alejandro Sica, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Nishi Shah, Amit Verma, Ira Braunschweig, Mendel Goldfinger
Publikováno v:
Haematologica, Vol 107, Iss 9 (2022)
Externí odkaz:
https://doaj.org/article/b68e1ebb6ef1462f834168c164e784cd
Autor:
Samarjit Patnaik, Pratyush Parida, Anjali Naik, Payalsmita Pradhan, Swapnasis Satpathy, Debasish Kisan, Manas Ranjan Nayak
Publikováno v:
2023 International Conference on Intelligent and Innovative Technologies in Computing, Electrical and Electronics (IITCEE).
Autor:
Kith Pradhan, Michelly Abreu, Amit Verma, Monika Paroder, Noah Kornblum, Aditi Shastri, Jennat Mustafa, Fariha Khatun, Ira Braunschweig, Lizamarie Bachier-Rodriguez, Lauren C. Shapiro, Kailyn Gillick, R. Alejandro Sica, Mendel Goldfinger, Alyssa De Castro, Joan Uehlinger, Karen Fehn, Richard Elkind, Randin Nelson, Ioannis Mantzaris, Anjali Naik, Kira Gritsman, Donika Binakaj, Felisha Joseph, Amanda Lombardo
Publikováno v:
Bone Marrow Transplantation. 56:1761-1763
Autor:
Aaditree Jaisswal, Anjali Naik
Publikováno v:
2021 IEEE Pune Section International Conference (PuneCon).
Publikováno v:
Proceeding of First Doctoral Symposium on Natural Computing Research ISBN: 9789813340725
Among all cancerous disease’s, lung cancer is the most driving reason for death in entire world. Early analysis and detection of the malady spares gigantic lives, flopping in which may prompt other extreme issues causing abrupt deadly demise. All i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7006a91b63f54ec53c93e58e708f8f51
https://doi.org/10.1007/978-981-33-4073-2_35
https://doi.org/10.1007/978-981-33-4073-2_35
Autor:
Joan Uehlinger, Anjali Naik, R. Alejandro Sica, Ira Braunschweig, Richard Elkind, Monika Paroder, Felisha Joseph, Fariha Khatun, Amit Verma, Donika Binakaj, Kailyn Gillick, Kira Gritsman, Mendel Goldfinger, Aditi Shastri, Jennat Mustafa, Amanda Lombardo, Tanim Jain, Carlo Palesi, Alyssa De Castro, Noah Kornblum, Randin Nelson, Karen Fehn, Kith Pradhan, Michelly Abreu, Kateryna Fedorov, Lizamarie Bachier-Rodriguez, Ioannis Mantzaris
Publikováno v:
Blood. 138:1833-1833
Background: Autologous hematopoietic stem cell transplant (auto-HSCT) is a commonly used treatment for multiple myeloma (MM) and for relapsed/refractory non-Hodgkin lymphomas (NHL) for patients who are 65 years old, and nearly half of those are in pa
Autor:
Christopher Nishimura, Donika Binakaj, Yang Shi, Lizamarie Bachier-Rodriguez, Carlo Palesi, Ulrich Steidl, Amanda Lombardo, Noah Kornblum, Xiaoxin Ren, Randin Nelson, Susan Sakalian, Fariha Khatun, Ira Braunschweig, Alyssa De Castro, Karen Fehn, Margaret McCort, Mendel Goldfinger, Murali Janakiram, Latoya Townsend-Nugent, Stephen Peeke, Zhu Cui, Rachel Bartash, Felisha Joseph, Ioannis Mantzaris, Rosmi Mathew, Monika Paroder, Kailyn Gillick, Anjali Naik, Yanhua Wang, Kira Gritsman, Nicole Chambers, Nishi Shah, Shafia Rahman, Kith Pradhan, Michelly Abreu, Joan Uehlinger, R. Alejandro Sica, Olga Derman, Astha Thakkar, Aditi Shastri, Karen Wright, Jennat Mustafa, Yoram A. Puius, Richard Elkind, Hao Wang, Xingxing Zang, Angelica D'Aiello, Amit Verma
Publikováno v:
Stem Cell Investig
BACKGROUND: Adoptive immunotherapy using CD19-targeted Chimeric antigen receptor T cells (CAR-T) has revolutionized the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Data is limited on the propensity of infections and lympho
Autor:
Mendel Goldfinger, Fariha Khatun, B. Hilda Ye, Felisha Joseph, Alvaro Alvarez Soto, Angelica D'Aiello, Shafia Rahman, Noah Kornblum, Ira Braunschweig, Anjali Naik, Kira Gritsman, Kith Pradhan, Kenny Ye, Amit Verma, Alyssa De Castro, Xingxing Zang, Zhu Cui, Olga Derman, Urvi A Shah, R. Alejandro Sica, Michal Kasher Meron, Lindor Qunaj, Kailyn Gillick, Hao Wang, Ioannis Mantzaris, Murali Janakiram, Astha Thakkar, Xiaoxin Ren, Aditi Shastri, Jennat Mustafa, Ulrich Steidl, Amanda Lombardo
Publikováno v:
Blood. 136:38-39
Introduction: Adult T cell leukemia lymphoma (ATLL) is a rare T cell neoplasm caused by the human T-lymphotropic virus (HTLV-1) virus. Although there are indolent subtypes it is often a highly aggressive and chemotherapy refractory malignancy. We fol
Autor:
L. Townsend Nugent, N. Chambers, Anjali Naik, Kira Gritsman, Fariha Khatun, Mendel Goldfinger, Noah Kornblum, Astha Thakkar, Kailyn Gillick, B. H. Ye, Carlo Palesi, R. Yusay, H. Noicely, Shafia Rahman, Murali Janakiram, Lizamarie Bachier-Rodriguez, Ioannis Mantzaris, D. Binakaj, Olga Derman, Ira Braunschweig, Zhu Cui, R. A. Sica, Felisha Joseph, Amit Verma, D. Adrianzen Herrera, R. Mathew, Randin Nelson, Ulrich Steidl, Amanda Lombardo, M. Abreu, Angelica D'Aiello, Aditi Shastri, Jennat Mustafa, Richard Elkind
Publikováno v:
Blood. 136:21-22
Introduction: Adult T-cell leukemia lymphoma (ATLL) is a rare hematologic malignancy caused by human T-cell lymphotropic virus (HTLV-1) with dismal cure rates and poor response to conventional chemotherapy. Allogeneic Hematopoietic Stem Cell Transpla
Autor:
Stephen Peeke, Xiaoxin Ren, Lizamarie Bachier-Rodriguez, Carlo Palesi, Joan Uehlinger, Ioannis Mantzaris, Monika Paroder, Fariha Khatun, R. Alejandro Sica, Karen Fehn, Karen Wright, Alyssa DeCastro, Murali Janakiram, Shafia Rahman, Randin Nelson, Amit Verma, Richard Elkind, Susan Sakalian, Ira Braunschweig, Christopher Nishimura, Mendel Goldfinger, Yang Shi, Zhu Cui, Anjali Naik, Aditi Shastri, Kailyn Gillick, Hao Wang, Yoram A. Puius, Kira Gritsman, Astha Thakkar, Latoya Townsend-Nugent, Angelica D'Aiello, Noah Kornblum, Yanhua Wang, Margaret E McCort, Rachel Bartash, Donika Binakaj, Felisha Joseph, Rosmi Mathew, Ryann Quinn, Ulrich Steidl, Amanda Lombardo, Nicole Chambers, Michelly Abreu, Olga Derman, Xingxing Zang, Nishi Shah
Publikováno v:
Blood. 136:10-11
Background: Adoptive immunotherapy using CD19-targeted Chimeric Antigen Receptor T-cells (CAR-T) has revolutionized the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). We have demonstrated the efficacy of FDA-approved axicabta